Gaining strength in treatment of spinal muscular atrophy
Lauren Elman, an associate professor of neurology, says Penn Medicine is the first center in Philadelphia to offer the SMA treatment program to adults after the Food and Drug Administration (FDA) announced the approval for Spinraza (nusinersen) in December 2016.
FULL STORY AT Penn Medicine News →